Can-Fite Initiates Compassionate Use Program for Namodenoson in the Treatment of Liver Cancer, Enrolls and Treats Patients
Based on encouraging Phase II results, patients with underlying CPB7 cirrhosis who lack a viable treatment option are now provided…